RYAN SPECIALTY HOLDINGS, INC.RYAN

Market cap
$15B
P/E ratio
Dec 31,
2021
Dec 31,
2022
Dec 31,
2023
Dec 31,
2024
Net income57163194230
Loss (income) from equity method investment in related party-1-0918
Amortization---158
Depreciation56910
Prepaid and deferred compensation expense-291231
Non-cash equity-based compensation-777079
Amortization of debt issuance costs---24
Amortization of interest rate cap premium-577
Deferred income tax expense-19717
Other Noncash Income Tax Expense--1810
(Gain) loss on Tax Receivable Agreement--6-112
Commissions and fees receivable – net-204422
Accrued interest liability-8120
Other current and non-current assets---21
Other current and non-current liabilities----7
Total cash flows provided by operating activities-336477515
Business combinations – net of cash acquired and cash held in a fiduciary capacity---1,709
Capital expenditures-153047
Asset acquisitions3438--
Repayments of prepaid incentives--0-
Total cash flows used in investing activities--22-476-1,756
Proceeds from Senior Secured Notes-394-1,187
Borrowings on Revolving Credit Facility---1,250
Repayments on Revolving Credit Facility---1,250
Debt issuance costs paid-2-26
Proceeds from term debt---108
Repayment of term debt-17178
Payment of contingent consideration-65-
Tax distributions to non-controlling LLC Unitholders---83
Receipt of taxes related to net share settlement of equity awards-7828
Taxes paid related to net share settlement of equity awards--927
Payment of Tax Receivable Agreement liabilities-81622
Dividends paid to Class A common shareholders---80
Distributions to non-controlling LLC Unitholders---22
Payment of accrued return on Ryan Re preferred units---2
Net change in fiduciary liabilities147-17-97-114
Total cash flows provided by (used in) financing activities-315-131,167
Effect of changes in foreign exchange rates on cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity--01-2
NET CHANGE IN CASH, CASH EQUIVALENTS, AND CASH AND CASH EQUIVALENTS HELD IN A FIDUCIARY CAPACITY-628-11-76